IDSA News - December 2014  (Plain Text Version)

Return to Graphical Version


In this issue:
Patient Care and Science
•  CDC Warns of Drifted Influenza A H3N2 Viruses
Clinical Practice Management
•  The Future of Telemedicine in ID
Policy and Advocacy
•  Fiscal Year 2015 Brings Stagnant Funding for ID, HIV
•  New Law to Incentivize Ebola Drug Development
Global ID
•  Science Speaks
Education and Resources
•  IDSA In-Training Exam is a Good Predicator of Performance on ID Certification Exam
•  IDSA Offers New MOC Modules on General ID and Infection Control
You and Your Colleagues
•  New Members
Top Stories
•  From the President: My Membership in IDSA is Part of My Identity as an ID Physician
•  Progress Continues on Several Antimicrobial Resistance Advocacy Fronts
•  IDSA Ebola Grants Still Available
•  Medical Scholars Program Applications Accepted Now Through February 2


CDC Warns of Drifted Influenza A H3N2 Viruses

As influenza season gets underway, the Centers for Disease Control and Prevention (CDC) issued an advisory regarding the potential for circulation of drifted influenza A viruses. The advisory was issued to re-emphasize the importance of the use of neuraminidase inhibitor antiviral medications when indicated for treatment and prevention of influenza, as an adjunct to vaccination.

IDSA offers two email services to help members stay informed of new drug approvals and similar updates from the Food and Drug Administration and CDC. Content includes a range of topics, including drug warnings, recalls, and outbreak investigations. Recent alerts have included:

Multistate Outbreak of Listeria Monocytogenes Infections Linked to Caramel Apples

FDA Approves Gardasil 9 for Prevention of HPV

Dietary Supplements Containing Live Bacteria or Yeast in Immunocompromised Persons: Warning - Risk of Invasive Fungal Disease

Fungal Contamination of Probiotic

IDSA members can sign up for these services online. (To subscribe, check the appropriate boxes to receive CDC’s Health Alert Network [HAN] messages and/or alerts from FDA, and provide your email address and name where indicated.)

Is Your Facility Experiencing Antibiotic Shortages?
IDSA members are urged to report drug shortages directly to FDA and to copy IDSA staff at